R156-17b-502. Unprofessional Conduct

  "Unprofessional conduct" includes:

  (1) violating any provision of the American Pharmaceutical Association (APhA) Code of Ethics for Pharmacists, October 27, 1994, which is hereby incorporated by reference;

  (2) failing to comply with the USP-NF Chapters 795 and 797 if such chapters are applicable to activities performed in the pharmacy;

  (3) failing to comply with the continuing education requirements set forth in these rules;

  (4) failing to provide the Division with a current mailing address within a 10 business day period of time following any change of address;

  (5) defaulting on a student loan;

  (6) failing to abide by all applicable federal and state law regarding the practice of pharmacy;

  (7) failing to comply with administrative inspections;

  (8) failing to return according to the deadline established by the Division, or providing false information on a self-inspection report;

  (9) violating the laws and rules regulating operating standards in a pharmacy discovered upon inspection by the Division;

  (10) abandoning a pharmacy or leaving prescription drugs accessible to the public;

  (11) failing to identify licensure classification when communicating by any means;

  (12) practicing pharmacy with an inappropriate pharmacist to pharmacy intern ratio established by Subsection R156-17b-606(1)(d) or pharmacist to pharmacy technician ratio as established by Subsection R156-17b-601(3);

  (13) allowing any unauthorized persons in the pharmacy;

  (14) failing to offer to counsel any person receiving a prescription medication;

  (15) failing to pay an administrative fine that has been assessed in the time designated by the Division;

  (16) failing to comply with the PIC or DMPIC standards as established in Section R156-17b-603;

  (17) failing to adhere to institutional policies and procedures related to technician checking of medications when technician checking is utilized;

  (18) failing to take appropriate steps to avoid or resolve identified drug therapy management problems as referenced in Subsection R156-17b-611(3);

  (19) dispensing medication that has been discontinued by the FDA;

  (20) failing to keep or report accurate records of training hours;

  (21) failing to provide PIC or DMPIC information to the Division within 30 days of a change in PIC or DMPIC;

  (22) requiring a pharmacy, pharmacist, or DMP to operate the pharmacy or allow operation of the pharmacy with a ratio of supervising pharmacist or DMP to other pharmacy personnel in circumstances that result in, or reasonably would be expected to result in, an unreasonable risk of harm to public health, safety, and welfare;

  (23) failing to update the Division within seven calendar days of any change in the email address designated for use in self-audits or pharmacy alerts;

  (24) failing to ensure, as a DMP or DMP clinic pharmacy, that a DMP designee has completed a formal or on-the-job dispensing training program that meets standards established in Section R156-17b-622; and

  (25) failing to make a timely report regarding dispensing of an opiate antagonist to the division and to the physician who issued the standing order as required in Section R156-17b-625.